Land: Südafrika
Sprache: Englisch
Quelle: South African Health Products Regulatory Authority (SAHPRA)
Janssen
INDICATIONS [/za_1289.html#1] [/za_1289.html#1] [/za_1289.html#1] CONTRA-INDICATIONS [/za_1289.html#1] [/za_1289.html#1] DOSAGE [/za_1289.html#1] [/za_1289.html#1] SIDE-EFFECTS [/za_1289.html#1] [/za_1289.html#1] [/za_1289.html#1] PREGNANCY [/za_1289.html#1] [/za_1289.html#1] OVERDOSE [/za_1289.html#1] IDENTIFICATION [/za_1289.html#1] [/za_1289.html#1] PATIENT INFORMATION IMODIUM® CAPS CAPSULES SCHEDULING STATUS: Schedule 2 PROPRIETARY NAME (and dosage form): IMODIUM ® CAPS CAPSULES COMPOSITION 2 mg LOPERAMIDE hydrochloride per capsule. PHARMACOLOGICAL CLASSIFICATION A.11.9 Medicines acting on gastro-intestinal tract. Antidiarrhoeals. PHARMACOLOGICAL ACTION IMODIUM CAPS inhibits hypermotility by direct action on the bowel wall. Its inhibition of peristalsis is the result of decreasing the activity of both the longitudinal muscles (preparatory and reflex phases) and the circular muscles (reflex phase). IMODIUM CAPS normalizes the stool in both acute and chronic diarrhoea. IMODIUM CAPS is incompletely absorbed from the gut, and it is almost completely metabolized in the liver where it is conjugated and excreted via the bile. IMODIUM CAPS is mainly eliminated via the faeces. INDICATIONS ADULTS AND CHILDREN 6 YEARS AND OLDER: IMODIUM CAPS is indicated for the control and symptomatic relief of acute and chronic nonspecific diarrhoea and inhibition of peristalsis and slowing of intestinal transit time in patients with ileostomies, colostomies and other intestinal resections. CHILDREN BELOW 6 YEARS OF AGE: IMODIUM CAPS is indicated for inhibition of peristalsis and slowing intestinal transit time. CONTRA-INDICATIONS IMODIUM CAPS is contra-indicated in patients with a known hypersensitivity to the medicine. IMODIUM CAPS is contra-indicated in infants under 24 months Lesen Sie das vollständige Dokument